Cholvax
PreclinicalBiologic
Cholvax is one of 2 biologic programs targeting Cholera. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1 competitor in Cholera
#DrugCompanyPhaseTrials
1Zofran
NovartisPhase 2
Cholvax
IInternational Centre for Diarrhoeal Disease Research, Bangladesh
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Immunogenicity1 trial
Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 2·NCT02742558·2,052 enrolled
Cholera1 trial
Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control
Recruiting·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Preclinical·NCT07685574·68,400 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Cholvax. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details